This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Massachusetts Institute of Technology, The United States Government as Represented by the Department of Veterans Affairs, University of California. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2014
Title: Akila Shanmugam: Innovator in Molecular Tweezers for Amyloid-Related Diseases
Introduction
Akila Shanmugam is an accomplished inventor based in Allen, TX (US). She has made significant contributions to the field of biomedical research, particularly in the treatment of amyloid-related diseases. Her innovative work focuses on developing novel compositions that inhibit the aggregation of amyloid proteins.
Latest Patents
One of her notable patents is titled "Molecular tweezers for the treatment of amyloid-related diseases." This invention provides compositions that effectively inhibit the aggregation of amyloidogenic proteins. The molecular tweezers designed by Shanmugam bind to lysine and/or arginine, thereby preventing the harmful aggregation of these proteins.
Career Highlights
Throughout her career, Akila Shanmugam has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. Her work has been instrumental in advancing the understanding and treatment of amyloid-related conditions.
Collaborations
Some of her notable coworkers include Gal Bitan and Aleksey Lomakin, who have collaborated with her on various research projects. Their combined expertise has contributed to the success of her innovative endeavors.
Conclusion
Akila Shanmugam's contributions to the field of biomedical research, particularly through her patent on molecular tweezers, highlight her role as a leading inventor in the treatment of amyloid-related diseases. Her work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile